Emerging Treatment for Anemia of CKD: HIF-PH Inhibitors

Goal:,The goal of this program is to improve the knowledge and competence of learners with regard to increased screening of patients with CKD for comorbid anemia and safely treating patients with supplemental iron/ESA or emerging novel therapies that increase endogenous EPO production.,Learning Objectives:,• Summarize the efficacy and safety data for HIF-PH inhibitors compared with conventional treatment of anemia of CKD,Additional details will be posted as soon as information is available.